Firm at a glance
Andera Partners is a platform private equity firm with an office in Madrid and approximately 6 billion under management, per its website [S1].
What they buy
Based on publicly reported transactions over the past 24 months, Andera Partners appears to pursue investments across healthcare, technology, and business services [S2]. The firm’s recent activity includes platform acquisitions in medical devices (Rivermark Medical, Spiro Medical, Adler Ortho), biotechnology (Tubulis, Agomab, Inventiva, Bioptimus), business consulting (Ayming), and industrial sectors (exceet Card Group, Tecnikabel) [S2]. The transaction pattern suggests a diversified approach with both growth equity and buyout investments across European markets.
Portfolio
No current portfolio company list was available in the public sources reviewed as of July 2026. Recent acquisitions reported in the past 24 months include:
**Healthcare & Life Sciences**
* Rivermark Medical (acquired May 2026) [S2]
* Spiro Medical (acquired January 2026) [S2]
* Alveus (acquired January 2026) [S2]
* Adler Ortho (acquired October 2025) [S2]
* Adcytherix (acquired October 2025) [S2]
* Tubulis (acquired October 2025, exited April 2026) [S2]
* Agomab (acquired October 2024, exited February 2026) [S2]
* Inventiva (acquired October 2024) [S2]
* Bioptimus (acquired January 2025) [S2]
**Technology & Industrial**
* exceet Card Group (acquired February 2026) [S2]
* Exciva (acquired January 2026) [S2]
* Tecnikabel (acquired July 2024) [S2]
* Skysun (acquired September 2024) [S2]
**Business Services**
* Ayming (acquired January 2025) [S2]
* Horus Finance (acquired November 2024) [S2]
* CDS Group (acquired February 2025) [S2]
* PM Studio (acquired November 2024) [S2]
* EG 427 (acquired February 2025) [S2]
Recent activity (last 24 months)
* July 2026: Closed Andera Expansion fund [S2]
* May 2026: Acquired Rivermark Medical [S2]
* May 2026: Exited Nostrum Group [S2]
* April 2026: Completed add-on acquisition of EIS Wire & Cable [S2]
* April 2026: Exited Tubulis [S2]
* February 2026: Completed add-on acquisition of HotelHub [S2]
* February 2026: Acquired exceet Card Group [S2]
* February 2026: Exited Agomab [S2]
* February 2026: Closed Acto V fund [S2]
* January 2026: Acquired Exciva, Alveus, and Spiro Medical [S2]
* November 2025: Exited Evommune [S2]
* October 2025: Acquired Adler Ortho, Adcytherix, and Tubulis [S2]
* October 2025: Exited ImCheck Therapeutics [S2]
* March 2025: Exited Kestra Medical Technologies and SoniVie [S2]
* January through February 2025: Acquired Bioptimus, Ayming, CDS Group, and EG 427 [S2]
* November 2024: Acquired Horus Finance and PM Studio [S2]
* October 2024: Acquired Agomab and Inventiva [S2]
* September 2024: Acquired Skysun [S2]
* July 2024: Acquired Tecnikabel [S2]
How this firm fits a seller
Andera Partners demonstrates an active acquisition program with approximately 18 platform investments completed in the trailing 24 months, suggesting capacity for new deals [S2]. The firm has also executed multiple exits during this period (Nostrum Group, Tubulis, Agomab, Evommune, ImCheck Therapeutics, Kestra Medical Technologies, SoniVie), indicating experience bringing portfolio companies to liquidity events [S2]. The transaction history shows particular depth in healthcare and life sciences businesses, which may appeal to sellers in medical device, biotechnology, and pharmaceutical services sectors. Add-on acquisition activity appears limited, with only two reported bolt-ons in the past year [S2].
Sources
[S1] https://www.anderapartners.com (as of 2026-07-15)
[S2] https://www.anderapartners.com/en/news/ (as of 2024-11-13)
Frequently asked questions
Does Andera Partners buy healthcare businesses?
Yes, healthcare and life sciences represent a substantial portion of Andera Partners’ recent investment activity. The firm acquired at least nine healthcare-related companies between July 2024 and July 2026, including medical device businesses (Rivermark Medical, Spiro Medical, Adler Ortho) and biotechnology platforms (Tubulis, Agomab, Inventiva, Bioptimus) [S2].
What companies has Andera Partners acquired recently?
Recent acquisitions include Rivermark Medical (May 2026), exceet Card Group (February 2026), Exciva (January 2026), Alveus (January 2026), Spiro Medical (January 2026), Ayming (January 2025), Bioptimus (January 2025), and CDS Group (February 2025), among others [S2].
Where is Andera Partners based and how big is the firm?
Andera Partners maintains an office in Madrid and reports approximately 6 billion under management, per its website [S1][S2]. Additional office locations were not disclosed in the public sources reviewed.
Is Andera Partners still actively acquiring?
Yes, Andera Partners appears highly active. The firm completed its most recent platform acquisition in May 2026 (Rivermark Medical) and closed a new fund (Andera Expansion) in July 2026 [S2]. The firm has completed approximately 18 platform acquisitions in the trailing 24 months through July 2026 [S2].
This profile is maintained by CT Acquisitions as an independent third-party reference. CT Acquisitions is not affiliated with, endorsed by, or a representative of the firm profiled. All facts sourced from publicly available materials as of the dates cited.